Statistics for NextCure (id:8430 NXTC)
Valuation metrics
Market cap
36.13M
Enterprise value
-43,219,892.00
Trailing P/E (ttm)
-0.53
Forward P/E
-0.90
PEG ratio
-0.90
Price/Sales (ttm)
Price/Book (mrq)
0.31
Enterprise Value/Revenue
Enterprise Value/EBITDA
0.72
Overview
Shares outstanding
28.01M
Float
18.64M
Shares short
73.77K
% Held by insiders
0.09%
% Held by institutions
0.58%
Average volume (10 days)
54.42K
Average volume (90 days)
Price summary
52-Week low
1.03
52-Week high
2.57
52-Week change
-2.52%
Beta
0.79
50-Day moving average
1.37
200-Day moving average
1.54
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-31.09%
Return on equity
-54.74%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-60,403,000.00
Net income to common (ttm)
-61,279,000.00
Diluted EPS (ttm)
-2.10
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
86.44M
Total cash per share (mrq)
3.09
Total debt (mrq)
6.29M
Total Debt/Equity (mrq)
7.36
Current ratio (mrq)
835.00%
Book value per share (mrq)
4.10
Cash flow
Cash flow statement
-45,830,000.00
Levered free cash flow (LFCF)
-26,329,000.00